1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

Otsuka Pharmaceutical Development And Commercialization Inc Clinical Trial

Otsuka Pharmaceutical Development And Commercialization Inc Europe

Back

Download Excel File

Show entries

Search:

Country/Continent	Trial Id	Start Date	Acronym	Study Title	Product Name	Primary Product	Synonym	Product Type	Biological Subtype	Industry Type	Biomarker/Moa	Disease/Indication	Therapeutic Area	Trial Status	Terminated Reason	Completion Date	Originaltrial Phase	Current Development Phase	Approved/Unapproved	Patent Expiry	Prediction Of Launch	Outcome measures	Sponsor/Collaborator	Primary Sponsor	Sponsor Type	Sponsor Classification	Licensing Deal	Historical Sales Data	Odd/Fta/Bta	Contact Detail	Contact Name	Designation	Contact Email	Contact Number	Contact Address	Gender	Age	Population Size	Study Design	Study Type	First Posted	Results First Posted	Last Update Posted	Location

Country/Continent	Trial Id	Start Date	Acronym	Study Title	Product Name	Primary Product	Synonym	Product Type	Biological Subtype	Industry Type	Biomarker/Moa	Disease/Indication	Therapeutic Area	Trial Status	Terminated Reason	Completion Date	Originaltrial Phase	Current Development Phase	Approved/Unapproved	Patent Expiry	Prediction Of Launch	Outcome measures	Sponsor/Collaborator	Primary Sponsor	Sponsor Type	Sponsor Classification	Licensing Deal	Historical Sales Data	Odd/Fta/Bta	Contact Detail	Contact Name	Designation	Contact Email	Contact Number	Contact Address	Gender	Age	Population Size	Study Design	Study Type	First Posted	Results First Posted	Last Update Posted	Location
Europe	2011-000467-27	2011-11-07	Subscribe Clival For more info	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety And Efficacy Of Flexible-Dose Once-Weekly Oral Aripiprazole In Children And Adolescents With Tourette S Disorder	Aripiprazole	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	Adrenergic Alpha1 Receptor Antagonist	Tourette Syndrome	Subscribe Clival For more info	HU(Completed)	Subscribe Clival For more info	--	Phase 3	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For More Info	--	Otsuka Pharmaceutical Development And Commercialization Inc	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	Subscribe Clival For more info	--	0	0	--	Interventional	--	--	--	Subscribe Clival For more info

Showing 1 to 10 of 10 entries (filtered from 68 total entries)

Previous1Next

Otsuka Pharmaceutical Development And Commercialization Inc Europe

Advance Filter

Last Update : 2005 To Apr 2023

Cookies & Privacy

Select cookies to accept